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Abstract
Background: Statistical learning (SL) techniques can address non-linear relationships
and small datasets but do not provide an output that has an epidemiologic
interpretation.
Methods: A small set of clinical variables (CVs) for stage-1 non-small cell lung cancer
patients was used to evaluate an approach for using SL methods as a preprocessing
step for survival analysis. A stochastic method of training a probabilistic neural
network (PNN) was used with differential evolution (DE) optimization. Survival scores
were derived stochastically by combining CVs with the PNN. Patients (n = 151) were
dichotomized into favorable (n = 92) and unfavorable (n = 59) survival outcome
groups. These PNN derived scores were used with logistic regression (LR) modeling
to predict favorable survival outcome and were integrated into the survival analysis
(i.e. Kaplan-Meier analysis and Cox regression). The hybrid modeling was compared
with the respective modeling using raw CVs. The area under the receiver operating
characteristic curve (Az) was used to compare model predictive capability. Odds
ratios (ORs) and hazard ratios (HRs) were used to compare disease associations with
95% confidence intervals (CIs).
Results: The LR model with the best predictive capability gave Az = 0.703. While
controlling for gender and tumor grade, the OR = 0.63 (CI: 0.43, 0.91) per standard
deviation (SD) increase in age indicates increasing age confers unfavorable outcome.
The hybrid LR model gave Az = 0.778 by combining age and tumor grade with the
PNN and controlling for gender. The PNN score and age translate inversely with
respect to risk. The OR = 0.27 (CI: 0.14, 0.53) per SD increase in PNN score indicates
those patients with decreased score confer unfavorable outcome. The tumor grade
adjusted hazard for patients above the median age compared with those below the
median was HR = 1.78 (CI: 1.06, 3.02), whereas the hazard for those patients below
the median PNN score compared to those above the median was HR = 4.0 (CI: 2.13,
7.14).
Conclusion: We have provided preliminary evidence showing that the SL
preprocessing may provide benefits in comparison with accepted approaches. The
work will require further evaluation with varying datasets to confirm these findings.
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Statistical learning (SL) techniques with kernel mappings can provide benefits when
addressing complicated decision problems [1-3]. These techniques are capable of cap-
turing non-linear input-output characteristics, operating on small datasets with feature
correlation, and do not require modeling or distribution assumptions. These attributes
are not derived without tradeoffs. These methods do not provide an output that has a
useful epidemiologic interpretation and their training often requires specialized techni-
ques. In contrast, logistic regression (LR) modeling, Kaplan-Meier analysis, and Cox
regression provide important epidemiologic interpretations and are used extensively
due to their availability. This report is an advancement of our earlier simulation work
[4] in adapting SL methods for epidemiologic application (see Appendix).
Lung cancer is the leading cause of cancer-related mortality in the world with more
than a million deaths each year [5]. Lung cancer is often diagnosed at an advanced
stage since early detection has been elusive [6]. Recent evidence indicates that lung
cancer mortality can be reduced when screening high-risk patients with a low-dose
computerized tomography (CT) scan [7]. Before this promising approach is incorpo-
rated into general practice, several important outstanding clinical issues have to be
addressed [6,7]. For patients with early stage lung cancer, local therapy with surgical
resection is associated with the best survival outcomes. This is limited to those with
non-small cell lung cancer (NSCLC), which accounts for approximately 85% of all
cases of lung cancer in the United States. Despite optimal surgical resection, recur-
rence of disease is noted in 30-75 percent of the patients based on the initial stage.
Development of prognostic models for predicting survival outcomes for patients with
NSCLC after resection will have important healthcare implications.
To adapt an SL methodology for epidemiologic application, a problem in NSCLC survi-
val prognosis was analyzed for stage-1 patients using a relatively small set of variables col-
lected routinely for patients of this kind, similar to those investigated previously [8]. A
probabilistic neural network (PNN) [9] was combined with LR modeling and survival ana-
lyses (i.e. Kaplan-Meier analysis and Cox regression) to demonstrate proof of concept.
This hybrid approach combines the strengths of the SL methodology with these important
epidemiologic techniques. The PNN is a statistically inspired neural network [9] that uses
a kernel mapping [10,11] to estimate the underlying probabilities. For the LR modeling
comparisons, the NSCLC dataset was dichotomized into two groups comprised of patients
with favorable or unfavorable survival outcomes. Raw clinical variables and a new patient
score variable formed with the modified PPN were considered as prognostic factors. Addi-
tionally, the PPN output was used as the study variable and compared with age using sur-
vival analysis. There are weight parameters within the PNN that must be estimated
properly. Differential evolution (DE) was used for this optimization problem [12]. Stochas-
tic methods were developed to provide feedback to the DE optimization and to derive the
patient PNN scores. We also evaluated this new system with the simulated datasets and
methods described previously [4], as discussed in the Appendix.
Methods
Dataset
The dataset was comprised of data from 151 NSCLC patients that underwent surgical
resection from 2002 - 2006. All data were selected retrospectively and consecutively.
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eration were selected. Ninety-two (n1) of these patients were alive at last contact (cen-
sored), and 59 (n2) patients died (incident) during the course of the contact interval.
The clinical variables abstracted from the patient files included age (i.e. age of the
patient at the time of procedure), gender (binary), history of smoking (binary), histol-
ogy sub-type (four categories), and tumor grade. Past or current smokers were categor-
ized as smokers (yes), otherwise patients were characterized as non-smokers (no). The
four histological sub-types were: adenocarcinoma (AC), squamous cell carcinoma
(SCC), large cell carcinoma (LCC), and adenosquamous carcinoma (ASC). Tumor
grade is a 1-3 integer scale describing cancer cell differentiation (a measure of abnorm-
ality) derived from pathology reports. This data was collected under an approved pro-
tocol by the Western Institutional Review Board.
Modeling Techniques
Favorable Outcome and Survival Analysis
The non-interaction LR model [13] was used to predict favorable and unfavorable sur-
vival outcome by dichotomizing the population into two groups. The 92 censored
patients were designated as the favorable survival outcome group defined as group-1 (i.
e. the censored group). Fifty-nine patients were designated as the unfavorable survival
outcome group defined as group-2 (i.e. the incident group). Other methods of dichoto-
mizing the population were considered but discarded as discussed in the Results Sec-
tion. Overall survival (OS) time was measured as the distance between the date of
procedure and the date of death for a given patient when applicable. Censor time was
measured as the distance between the date of the procedure and the date that a given
patient was censored, when applicable. The LR model was referenced to predict the
probability of a favorable outcome. Age was treated as a continuous variable with inte-
ger accuracy, and grade was considered as a three state continuous integer variable
(grades 1-3). Histology (four-state) and gender (two-state) were treated as categorical
variables. Age and grade were combined to form a continuous patient score (or z)
using a variation of the PNN. The reasons for this follow from the LR modeling (non-
hybrid) findings and that they were treated as continuous variables, whereas the
remaining variables were categorical or binary and not strictly amendable to probability
density estimations. Kaplan-Meier product-limit estimators and Cox regression were
used for the survival probability curve analyses. In this analysis, two groups were
formed by choosing the median age and median PNN score as the separation points.
The other relevant variables were introduced with both age and PNN score to evaluate
their influence on the respective survival probability curves.
For the LR modeling comparisons, odds ratios (ORs) were used to assess measure-
ment association. For age and PNN score (i.e. the continuous variables), the LR model
coefficients were re-scaled to provide ORs per standard deviation (SD) change for each
variable. The ORs for grade were cited in per unit increase. The area under the recei-
ver operating characteristic curve (Az) was used to measure the predictive capability
for a given model. The Az was estimated with three methods. First, to assess the SL
training and patient scores, the definition of Az was applied [14] using the respective
distributions. Secondly, the Az quantities for the LR models were generated within the
SAS (SAS Institute, NC) software package using the output of the LR model (same
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square Wilcoxon (more sensitive to shorter term survival differences) and log-rank
(more sensitive to longer term survival differences) tests were used for differences in
stratification. Hazard ratios (HRs) were estimated with Cox Regression. Thirdly, Az
was also derived from Cox regression and is a measure of the agreement between the
model and actual time-to-event outcome [15]. For the ORs and HRs 95% confidence
intervals (CI) were provided. The survival analysis was also performed with SAS.
Probabilistic Neural Network and Kernel Methods
We implemented a variation of the PNN using a Gaussian kernel, although there are
many kernels meeting the established criteria [16]. Paralleling our earlier work [17],
the distance metric for a d dimensional input vector (i.e. the relevant clinical variables)
is given by
Di(w)=
d 
j=1
(wj − wij)
2
σ2
j
, (1)
where i is the patient index, wij is the j
th component of the i
th sample’s input vector,
and wj is the j
th component of a prospective test sample’s input vector w.T h es i g m a -
weights, sj , were estimated with DE optimization. Specifically, d = 2, with wi1 =a g e ,
and wi2 =g r a d ef o rt h ei
th patient. The probability density estimation [10,11] for w
with n training samples is expressed as
g(w)=
1
n
n 
i=1
exp[−Di(w)] =
1
n
n 
i=1
k(w,wi). (2)
Normalization factors are discussed below. The PNN was constructed with the above
formulism for each group. For group-1, the density for w is given by
g1(w)=
1
n1
n1 
i=1
k(w,wi). (3)
For a given w, the sum on wi is taken over group-1 samples only with n = n1. The g2
(w) density was estimated the same way by restricting the sum on wi to the group-2
samples with n = n2. In both the g1 and g2 estimations, w included samples from both
groups. Equation (3) also represents a function mapping of the vectors w and wi ,
where each element of the summation represents the inner product of the mapped
vectors [3], rendering a nonlinear problem tractable with the proper choice of kernel.
Assuming prior probabilities and misclassification costs are equal, the PNN classifier
[9] is expressed as
g1(w)
g2(w)
> c, (4)
where c is a constant. For classification when this condition is met, w belongs to
group-1. Because we were interested in developing a score for each patient (not classi-
fication), we formed this score with the above expression
patient − score =
g1(w)
g2(w)
. (5)
Behera et al. BioMedical Engineering OnLine 2011, 10:97
http://www.biomedical-engineering-online.com/content/10/1/97
Page 4 of 15The multivariate normalization factors were not important because both g1 and g2
contained the same sigma-weights. These scores were used with LR modeling and the
survival analysis. Because the above expression is always positive and can be large, we
used z = ln (patient - score) in the analyses as the PNN derived patient score and per-
formed a range compression technique to reduce statistical outlier interference in the
LR modeling.
Probabilistic Neural Network Training and Operation
The sigma-weights for the kernel in the PNN must be estimated properly. A stochastic
cross-validation technique was developed in combination with DE to estimate these
weights. DE is also a stochastic global optimization strategy that is self-organizing via
feedback. We developed the algorithm described by the founders of DE [12] and used
their notation in this description. Important points underlying DE were discussed in
our previous work [17] and are briefly discussed here. We used a uniform crossover Cr
= 0.9 and scale factor F = 0.2. The zero-generation feature vector population (i.e. NP =
40 vectors) was initialized with uniformly distributed random variables with compo-
nents constrained to this range [0.01, 1.5]. For a given generation, the DE process con-
structs a mutant vector (or vg) by stochastic perturbation from the current population
of x, where g is the generation index. From this, a candidate vector (or ug)i sc o n -
structed that competes with a given current generation vector, xg , selected at random
in such a way that it was not involved with the vg (or ug) construction. Possible solu-
tions (xg and ug) compete against each other using feedback from the optimization
problem. The winner moves to the next generation of x (i.e. g+1). For a given genera-
tion there are NP competitions. In our DE application, Az was the feedback measure
using the two patient-score distributions derived from Eq. (5). The feedback to the DE
was formed by ensemble averaging derived with bootstrap sampling [18]. For one DE
generation, Nt bootstrap populations were generated. To form a given bootstrap popu-
lation, n2 samples were selected randomly from group-1 and from group-2 with repla-
cement. We keyed on n2 as not to bias the sampling to the larger population. One
sample from each class was selected randomly and used as w in Eq. (5) to generate the
respective patient-score quantities. The remaining samples were used to build the
respective wi populations in Eq. (5). We refer to this process as a leave two-out sto-
chastic cross-validation technique. When Nt = 1, the process is similar to the conven-
tional leave two-out approach using different realizations of the population. This
process then was repeated Nt (i.e. training) times and the average Az was used as feed-
back for one DE generation. The process was terminated after G generations. The
weights that provided the largest Az were carried over to the analysis and used to gen-
erate z for each patient using stochastic methods and ensemble averaging. For a given
w, a bootstrap population was generated from the wi population and the respective z
was generated for all n1 and n2 patients. Each patient’szw a sd e r i v e df r o me n s e m b l e
averaging by repeating this process for Nsc times. The training process and final score
g e n e r a t i o nf l o wa r es h o w ni nt h eF i g u r e1schema. As provided in the Appendix, we
assessed the system described above with both simulated data using the same methods
described previously [4] and with holdout cross-validation techniques to show internal
validity. The software for the PNN and DE applications was developed by the authors
using the IDL (ITT Visual Information Solutions, Boulder CL) programming language.
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Favorable Outcomes
The patient characteristics are summarized in Table 1. To assess inter-group differ-
ences in these clinical variables, a t-test was used for continuous variable comparisons,
and the binomial proportional test (with the normal approximation) was used for the
categorical or binary variable comparisons, where applicable. As shown in the right
most column of Table 1, the censored group patients are younger, more likely female,
tend to have grade 1 disease, and the smoking status is similar. The censored group is
more likely to have AC in comparison with the incident group, whereas the other his-
tology-type and other grade differences are less clear in the summary format. The stan-
dard LR modeling (i.e. raw clinical variables or accepted approach) findings are shown
in Table 2 (top). A one SD increase in age (SD = 8.68 years) indicates the respective
patient is 0.60 times more likely to be in group-1 (or 1.66 times more likely to be in
group-2 and not survive), which was significant. The OR for the tumor grade adjusted
model shows a trend. A unit increase in grade indicates a given patient is about 1.5
t i m e sm o r el i k e l yt ob ei ng r o u p - 2 ,b u tt h i sassociation was not significant. When
introducing gender with age and grade, the gender association OR = 0.38 was signifi-
cant indicating females are 2.6 times more likely have a favorable outcome. The adjust-
ments for grade and gender had a minor influence on the age ORs. However, adding
these variables increased the model’s predictive capability: Az = 0.636 (age alone), Az =
Figure 1 Modified probabilistic neural network stochastic training and z generation flow diagram.
This schema shows the modified probabilistic neural network (PNN) training flow for the differential
evolution (DE) sigma-weight vector construction, competition, and feedback from the g to the g+1
populations. The sigma-weight vectors xg and ug compete for the next generation. The receiver operating
characteristic curve area (Az) from the stochastic cross-validation is derived with ensemble averaging to
reduce the chance of passing outliers back to the vector competition. When g = G, the evolution stops
and the sigma-weights are used in the PNN to generate z for each patient stochastically with ensemble
averaging. The z quantities are then passed to the survival and logistic regression analyses.
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Page 6 of 150.657 for age and grade, and Az = 0.703 for age, grade, and gender. The standard error
(SE) in Az was estimated as SE = 0.03. Adding histological-type and smoking status
with gender and grade produced marginal influences on the relationships (not shown).
In summary, younger age, lower-grade, and gender (female) confer a favorable survival
outcome. The weak association for grade with survival could be due to limited sam-
ples, the association is truly marginal, or the relationship is complicated and cannot be
captured with the LR model. To assess these possibilities, grade was combined with
age using a variation of the PNN classifier.
Table 1 Patient characteristics.
Characteristic Incident n Incident mean/SD or % Censored n Censored mean/SD or % p-value
Age 59 69.58/7.85 92 65.42/8.84 0.0038*
Grade 59 2.22/0.62 92 2.10/0.68 0.2651*
One 6 10.17% 17 18.48% 0.1656
Two 34 57.63% 49 53.26% 0.5988
Three 19 32.20% 26 28.26% 0.6053
Gender
Male 38 64.41% 34 36.96% 0.0010
Female 21 35.59% 58 63.04% 0.0010
Histology subtype
Adenocarcinoma 29 49.15% 58 63.04% 0.0919
Squamous 25 42.37% 20 21.74% 0.1510
Large Cell 3 5.08% 11 11.96% 0.1555
Adenosquamous 2 3.39% 3 3.26% 0.9655
Smoking status
Non-Smoker 12 20.34% 19 20.65% 0.9629
Smoker 47 79.66% 73 79.35% 0.9629
The patient characteristics are summarized in this table. The incident column refers to group-2 patients (unfavorable
survival outcome) and the censored column refers to group-1 patients (favorable survival outcome). The mean and
standard deviation (SD) are provided for the continuous variables and percentages (%) are provided for the other
variables by group. The number of patients (n) for each variable is given for each group. The incident and censored
group characteristics were compared with either the t-test (*) or binomial proportional test. The relevant p-values are
provided in the last column (right).
Table 2 Odds Ratios.
Model SD Age OR Az Covariate Unit Covariate OR
Accepted
Age 8.681 0.60
(0.42, 0.86)
0.636
Grade adjusted 8.681 0.58
(0.40, 0.83)
0.657 Grade 1 0.68
(0.40, 1.15)
Grade and Gender adjusted 8.681 0.63
(0.43, 0.91)
0.703 Grade 1 0.73
(0.42, 1.25)
Gender Male vs Female 0.38
(0.19, 0.78)
Model SD ln(z) OR Az Covariate Unit Covariate OR
Hybrid
z (Age and Grade) 1.695 4.15
(2.15, 8.01)
0.763
Gender adjusted 1.695 3.67
(1.88, 7.16)
0.778 Gender Male vs. Female 0.50
(0.24, 1.05)
The odds ratios (ORs) and 95% confidence intervals (CIs) are provided parenthetically for the variables used in the
logistic regression modeling. The ORs for the continuous variables (age and z) are cited per standard deviation (SD)
increase in the respective variable or as a unit increase (grade) while controlling for the other variables (covariates)
when applicable. The z variable includes grade and age simultaneously. The ORs for the other covariates are listed in
the column to the right. The area under the receiver operating characteristic curve (Az) is also provided for each model.
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0.013610961 and s2 = 0.35805283 for age and grade, respectively. Using Nt =1p r o -
duced training Az values between 0.700-0.830. Choosing Nt = 5 gave consistent find-
ings and was used in the analysis. The stochastic cross-validation performance
coinciding with these weights gave Az = 0.710 with SE = 0.03 after three generations
(G = 3), which is in agreement with the Az derived from holdout cross-validation ana-
lysis (see Appendix). We used these parameters to generate z for each patient with Nsc
= 20. Processing age and grade separately through the PNN gave Az = 0.656 for age
and Az = 0.538 for grade, which are statistically similar to the Az values when asses-
sing these variables individually without the PNN processing. The continuous hybrid
LR findings are shown in the bottom of Table 2. The combined effect shows that for a
SD increase in z (SD = 1.69), the respective patient is about 4.15 times more likely to
experience a favorable survival outcome (or incident group member is 0.24 more likely
to experience a favorable outcome) with Az = 0.763, which was significantly larger (p
= 0.0062) than that provided by the respective age and grade LR model. Due to the
way the PNN was defined, increasing z was protective, whereas increasing in age was
not. Adjusting for gender increased the predictive capability of the model with Az =
0.778 (SE = 0.03), although the gender OR lost significance. Gender also reduced the
association for z with OR = 3.67 per standard deviation increase, which was a stronger
association than provided by age in the corresponding model. The Az derived from the
hybrid model (z and gender) was significantly greater than that of the corresponding
LR model with age, grade, and gender (p = 0.0173). As above, including histology-type
or smoking status with z had a marginal influence on the relationships (not shown).
To evaluate the effect of the kernel mapping on age and grade, the LR model outputs
for the two models were plotted as a function of grade and age. The left side of Figure
2 shows the grade plots for the LR (accepted approach with age and grade) model.
The respective grade plots for the hybrid LR model using z (age and grade combined)
are shown on the right side of Figure 2. In these plots black was used to denote cen-
sored group samples and red to denote incident group samples. The grade 1 plots for
both models exhibit similar behavior for the lower ages and show that patients 65
years of age and younger are more likely to be in censored group. The hybrid model
separates some older grade 1 patients in contrast with the accepted LR model. A com-
parison of the grade 2 plots shows that the hybrid model provides separation for the
younger, middle age, and some upper age patients, whereas the respective accepted LR
model produces confusion between the groups. In the grade 3 plots, both models pro-
vide separation for lower age patients, whereas the hybrid model shows group separa-
tion in the middle-age range as well. Because z is a composite variable and difficult to
interpret, the associations between age, grade, z, and group status shown in Figure 2
are also summarized in Table 3. This provides the average values for age and the z
variables separated by grade and group.
We used the OS and censor times to form two groups because of the separation
between the respective distribution means. The favorable group had a mean censor
time of 3.97 years (i.e. mean known OS time, which is a low-side limit assuming these
patients did not expire the day after study-contact), whereas the incident group had a
mean OS time of 2.20 years (data not shown). The minimum censor time (2.35 years)
is greater than the mean OS time for the incident group indicating validity of the
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ered, such as choosing a cutoff-point at given OS time but this technique added ambi-
guity with those censored on the left-side of the cut-point and left few samples on the
right-side of the cut-point when considering four or five year OS times as the
demarcation.
Survival Analysis
The Kaplan-Meier survival probability curves for age are shown in Figure 3. The
related findings are provided in Table 4. The hazard for age was HR = 1.72 indicating
that upper-age group membership is significantly more hazardous than lower-age
group membership. Roughly, 37% of the lower-age group survived past 7 years,
whereas about 29% of the upper-age group survived past this time. The longer-term
Figure 2 Logistic regression model output for each tumor grade. The plots on the left show the
logistic regression model probabilities (P) using the age and grade variables as the model inputs for each
tumor grade. The plots on the right show the respective hybrid logistic regression model probabilities (P)
using the variable z (i.e. age and grade combined with the probabilistic neural network) as the model
input. Because there are overlapping points (patients with the same grade and age), some points are not
distinguishable. The censored group (black) is compared with the incident group (red). The curves were
fitted with a cubic spline.
Table 3 Age and z relationships.
Censored group Grade 1 Grade 2 Grade 3 All
n1 7 4 9 2 6 9 2
Age (mean) 66.41 66.27 63.19 65.42
z (mean) 2.11 3.91 3.12 3.36
Incident group Grade 1 Grade 2 Grade 3 All
n 6 34 19 59
Age (mean) 73.83 68.88 69.47 69.58
z (mean) 0.26 1.37 -0.07 0.8
This table gives the mean values for age and z as a function of tumor grade and censored/incident group status. The
number (n) of patients in each category is also provided.
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grade induced a greater hazard with HR = 1.78, but the change in the survival curves
when controlling for grade was not significant in either the short term (p = 0.074) or
the longer-term (p = 0.091). The addition of gender caused a significant change in the
survival curves compared with age alone for both the short term (p < 0.002) and long-
term survival (p < 0.005) but the HR = 1.64 lost significance. The grade and gender
adjusted hazard for age was HR = 1.68 (also lost significance). The statistical test find-
ings for age and gender are provided in Table 5 (top rows). The survival probability
curves for z are shown in Figure 4 and the HRs are provided in Table 4. There is a sig-
nificant survival difference between these upper and lower-z groups both in the short
term (p < 0.0001) and long term (p < 0.0001) with HR = 0.25 indicating those in the
upper-z group are at a significantly reduced hazard compared with those in the lower
z group (i.e. the hazard for those in the lower-z membership was HR = 4.0). About
52% of the upper-z group survived past 7 years, whereas as about 11% of the lower-z
g r o u ps u r v i v e dp a s tt h i st i m e .T h ea d d i t ion of gender also produced a significant
change in both short term (p = 0.0146) and the longer term (p = 0.0319) with HR =
0.28 (HR = 3.57 for lower-z membership). The associated statistical comparisons for z
and gender are provided in Table 5 (bottom two rows). As shown in Table 4, the
hybrid Cox model (i.e. using z) showed greater concordance (Az = 0.691) with the out-
come than that of the Cox model (accepted approach) using age and grade (Az =
0.606), but the difference in Az was a trend (p = 0.056). Likewise, the Az comparison
between the hybrid Cox model using z and gender (Az = 0.738) with the Cox model
using age, grade, and gender (Az = 0.677) showed a similar trend (p = 0.0747). The
Figure 3 Survival probability curves for age. The upper and lower-age groups were formed by
dichotomizing the total collection of patients at their median age. The lower-age curve (upper blue curve)
exhibits better survival characteristics than the upper-age group (bottom brown curve).
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dies [8,19].
Discussion
A technique for incorporating SL methods with epidemiologic analyses was illustrated.
The approach used ensemble averaging based on bootstrap sampling. These prelimin-
ary findings indicate the hybrid approach provided benefits. With this data, the hybrid
approach provided greater Az in the logistic regression modeling and greater hazard
relationships in the survival analyses than that of the accepted approaches. The inter-
nal validity of our findings is supported by the analysis provided in the Appendix. This
approach represents a framework that is easily generalized. We used the SL output as
the input into LR model and survival analysis, essentially combining the strengths of
the various modeling techniques. In this capacity, the SL device was operating as fron-
tend preprocessing step for these accepted analysis techniques. Processing the SL out-
put with these approaches provides a mechanism for converting the SL output into
epidemiologic metrics (i.e. ORs and HRs). We used a relatively simple SL device to
demonstrate the concept with a two-class problem. This specific approach can be
extended to include more than two classes (e.g. death, greater than three, and five year
Table 4 Hazard relationships for dichotomous age and z.
Model Age Hazard Ratio Az
Accepted
Dichotomous Age 1.72 (1.02, 2.90) 0.5792
Grade adjusted 1.78 (1.06, 3.02) 0.606
Gender adjusted 1.64 (0.96, 2.78) 0.669
Grade Gender adjusted 1.68 (0.99, 2.85) 0.677
Model z Hazard Ratio Az
Hybrid
Dichotomous z 0.25 (0.14, 0.47) 0.691
Gender adjusted 0.28 (0.15, 0.53) 0.738
For the age and z variables, two groups were formed using the respective distribution median as the cut-point and
compared. The hazard ratios (HRs) are provided parenthetically with 95% confidence intervals. The area under the
receiver operating characteristic curves (Azs) derived from Cox regression models are also provided. Because age and z
translate inversely with respect to hazard, increased age confers a greater hazard while decreased z confers a greater
hazard. To make HR comparisons of z with age, the reciprocal of the z HR is required.
Table 5 Survival probability statistical test summaries.
Model Test Chi-Square DF p-value
Accepted
Dichotomous Age over Strata Log-Rank 4.1784 1 0.0409
Wilcoxon 3.4073 1 0.0649
Dichotomous Age and Gender over Strata Log-Rank 12.7383 3 0.0052*
Wilcoxon 13.5117 3 0.0043*
Hybrid
Dichotomous z over Strata Log-Rank 22.7597 1 < 0.0001
Wilcoxon 14.9418 1 0.0001
Dichotomous z and Gender
over Strata
Log-Rank 28.1863 3 < 0.0001*
Wilcoxon 22.4886 3 < 0.0001*
The statistical tests findings for the various age an z related survival probability curves are provided with the degrees of
freedom (DF). When comparing more than two survival curves (*), the hypothesis that all the curves were the same was
tested against the alternative that at least one curve was different.
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mial logistic regression can address multiple level outcomes. It could be argued that
the LR modeling was suboptimal because the time-to-event variable resolution was
reduced to a coarser dichotomous variable. However for a specific set of variables, the
LR output provides a different metric (i.e. probability of having a favorable outcome)
than that provided by Cox regression (i.e. instantaneous relative risk). Thus, the resolu-
tion reduction is the price paid for an alternative output. More generally, the same
hybrid approach is applicable for the output of any other type of SL method or deci-
sion device (e.g. support vector machines, kernel based partial least squares, or other
types of neural networks).
There are several limitations with our findings. The analysis was performed with a
limited number of samples derived retrospectively. Censoring limits the survival time
estimations. Although the DE is a robust approach, there is no guarantee that it will
converge indicating that the findings may be less than optimal. The generation termi-
nation limit, G = 3, was empirically set because we found that letting the process
evolve over many generations produced weights that were too finely tuned and did not
provide performance consistency between the training evaluation and the final score
assessments. Because the dataset was limited, further evaluation using both simulation
methods and holdout cross-validation with the z-score was provided in the Appendix.
The findings from the hybrid modeling will require further evaluations with different
datasets to show generalization. In principle to use a system as illustrated here in prac-
tice, the sampled patient population should be representative of stage-1 lung cancer
patients in general. The operation of this system with new datasets would relegate this
Figure 4 Survival probability curves for z. The upper and lower-z groups were formed by
dichotomizing the total collection of patients at their median z value. The upper-z group (upper brown
curve) exhibits better survival characteristics than the lower-z group (bottom blue curve). These findings
incorporate tumor-grade with age via the probabilistic neural network combination.
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spective samples as w(without further training) to generate z for assessing survival
probabilities or predicting favorable outcomes. The SL method was trained with a
dichotomized survival output, which was the same output used to train the hybrid LR
model. Therefore, the corresponding hybrid LR model (or the survival curve separa-
tion) could be confounded by the z variable if the choice of kernel or weights were
suboptimal. Determining the optimal kernel was beyond the scope of this research.
Generalization of the LR model and incorporating kernel based techniques into epi-
demiologic survival analyses represents a diverse field of inquiry. Earlier research used
a PNN and LR modeling to predict survival in early stage NSCLC but did not fuse the
models [20]. Logistic regression is a member of a family of generalized linear models.
Replacing the LR argument with various forms of smooth functions has provided bene-
fits in the study of colon-cancer [21], heart-disease [22] and infant mortality [23].
Other researchers have incorporated univariate kernel density estimations for studying
prostate-cancer [24], health disparities [25], and nutrient intake [26]. Similarly, univari-
ate kernel density estimations have been used to estimate summary measures that
were incorporated into LR modeling in fast-food consumption studies [27]. Our work
differs from this other work in that the PNN application makes no assumption con-
cerning the functional relationship of the variables under study and we incorporated
the measures into LR.
Conclusion
An SL methodology comprised of DE optimization, a kernel mapping, and stochastic
ensemble averaging was presented as an illustration to generalize widely used analysis
techniques. The technique gives the SL methodology an epidemiologic interpretation.
Although we used a specific example, the framework applies to all situations where LR
modeling and survival analysis are appropriate. The approach can be easily modified to
include as many input variables as required and new samples can be added into the
training procedure with the proper clinical feedback indicating the system can learn
continually without computer processing demands due to its relative simplicity. The
system will require further evaluation with different datasets before it can be applied in
practice.
Appendix
Additional evaluation was performed to assess the PNN z score method that included
a simulation study and holdout cross-validation analysis.
Simulation evaluation
A simulation was performed to assess the training, optimization, and patient scoring
system shown in Figure 1 under ideal conditions. We used the same simulation meth-
ods with two correlated input features and non-linear separation boundary as
described in our earlier work [4]. We used 200 samples per class giving 400 samples
total as previously for the training dataset. We used this training dataset to estimate
the sigma-weights using the algorithm described above (Figure 1). We used the same
stochastic averaging (N t =5 ,a n dN sc = 20) and bootstrap methods. We stopped the
differential evolution optimization for G = 3 as above, which gave two sigma-weights
(0.291156797, 0.0872920) with a training Az = 0.987. The training dataset was then
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luation dataset of the same dimension (200 per class giving 400 samples total) that was
not used in the sigma-weight generation. These new samples were then used as w in
the stochastic score generation and evaluated. This evaluation gave Az = 0.979. This
shows in principle, the system is viable and that the training distribution must be
representative of the population. It is also worth noting that the separation provided
by this modified PNN system was larger than that described previously using a differ-
ent statistical learning system when processing the same type of simulated datasets (i.e.
Az ≈ 0.950).
Holdout cross-validation
To assess the internal validity of the approach, we used the scheme shown in Figure 1
with one main difference. Two patient samples (one sample from each group) were
selected at random and held out (i.e. leave two-out cross-validation) of the training
process To slow the DE convergence, we set Cr = 0.1. The system comprised of the
remaining n-2 patients was trained for 20 DE generations for each holdout pair. These
n-2 samples were used for training and for generating training z scores (age combined
with grade with the PNN) and Azs. For each DE generation, a bootstrap population
was generated from the fixed n-2 population and an Az was generated. The weights
that gave the largest Az for the 20 DE generations were used to generate the z scores
for the two samples (holdout pair). We used stochastic averaging for the output scores,
where 20 bootstrap populations were generated from the fixed n-2 training samples
(generated 20 scores for each of the two left out samples). This process cycled (i.e.
choosing another pair at random leaving a new n-2 training population for the next 20
DE generations) until all patients received a score. The resulting leave two out cross-
validations gave Az = 0.700, indicating the approach was internally valid.
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